Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of 
Small Cell Lung Cancer

With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Benlin HUANG, Yong DUAN
Formaat: Artigo
Taal:Chinês
Gepubliceerd in: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-04-01
Reeks:Chinese Journal of Lung Cancer
Onderwerpen:
Immune checkpoint inhibitors
Small cell lung cancer
PD-1
PD-L1
CTLA-4
Online toegang:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items